Market Currents
Actavis, which is being acquired by Watson Pharmaceuticals (WPI +0.2%), says that on June 29 it...
-
Thursday, July 5, 2012, 11:33 AM ETActavis, which is being acquired by Watson Pharmaceuticals (WPI +0.2%), says that on June 29 it received tentative approval from the FDA for Guanfacine Extended-Release Tablets, a generic equivalent to Shire's (SHPGY -2.5%) Intuniv. Intuniv had US sales of approximately $342M for the 12 months ending March 31.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
